Submit
Search
Submit
Menu

  • Information

  • References

  • Contents

  • [1]C. G. Bönnemann, C. H. Wang, S. Quijano-Roy, N. Deconinck, E. Bertini, A. Ferreiro, F. Muntoni, C. Sewry, C. Béroud, K. D. Mathews, S. A. Moore, J. Bellini, A. Rutkowski and K. N. North: Diagnostic approach to the congenital muscular dystrophies. Neuromuscular Disord, 24(4), 289-311 (2014)

  • [2]K. H. Holt and K. P. Campbell: Assembly of the Sarcoglycan Complex: Insights for muscular dystrophy. J Biol Chem, 273(52), 34667-34670 (1998)

  • [3]E. P. Hoffman, R. H. Brown, Jr. and L. M. Kunkel: Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell, 51(6), 919-28 (1987)

  • [4]J. M. Ervasti, K. Ohlendieck, S. D. Kahl, M. G. Gaver and K. P. Campbell: Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature, 345(6273), 315-319 (1990)

  • [5]B. J. Petrof, J. B. Shrager, H. H. Stedman, A. M. Kelly and H. L. Sweeney: Dystrophin protects the sarcolemma from stresses developed during muscle contraction. PNAS, 90(8), 3710-3714 (1993)

  • [6]M. Yoshida, H. Hama, M. Ishikawa-Sakurai, M. Imamura, Y. Mizuno, K. Araishi, E. Wakabayashi-Takai, S. Noguchi, T. Sasaoka and E. Ozawa: Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy. Hum Mol Gen, 9(7), 1033-40 (2000)

  • [7]T. Yoshida, Y. Pan, H. Hanada, Y. Iwata and M. Shigekawa: Bidirectional signaling between sarcoglycans and the integrin adhesion system in cultured L6 myocytes. J Biol Chem, 273(3), 1583-90 (1998)

  • [8]K. M. Bushby: Diagnostic criteria for the limb-girdle muscular dystrophies: report of the ENMC Consortium on Limb-Girdle Dystrophies. Neuromuscular Disord, 5(1), 71-4 (1995)

  • [9]C. E. Jackson and D. A. Strehler: Limb-girdle muscular dystrophy: clinical manifestations and detection of preclinical disease. Pediatrics, 41(2), 495-502 (1968)

  • [10]S. L. Roberds, F. Leturcq, V. Allamand, F. Piccolo, M. Jeanpierre, R. D. Anderson, L. E. Lim, J. C. Lee, F. M. Tome, N. B. Romero and et al.: Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell, 78(4), 625-33 (1994)

  • [11]C. G. Bönnemann, R. Modi, S. Noguchi, Y. Mizuno, M. Yoshida, E. Gussoni, E. M. McNally, D. J. Duggan, C. Angelini and E. P. Hoffman:β-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nature Genet, 11(3), 266-73(1995)

  • [12]L. E. Lim, F. Duclos, O. Broux, N. Bourg, Y. Sunada, V. Allamand, J. Meyer, I. Richard, C. Moomaw, C. Slaughter and et al.: β-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nature Genet, 11(3), 257-65 (1995)

  • [13]S. Noguchi, E. M. McNally, K. Ben Othmane, Y. Hagiwara, Y. Mizuno, M. Yoshida, H. Yamamoto, C. G. Bonnemann, E. Gussoni, P. H. Denton, T. Kyriakides, L. Middleton, F. Hentati, M. Ben Hamida, I. Nonaka, J. M. Vance, L. M. Kunkel and E. Ozawa: Mutations in the Dystrophin-Associated Protein γ-Sarcoglycan in Chromosome 13 Muscular Dystrophy. Science, 270(5237), 819-22 (1995)

  • [14]V. Nigro, E. de Sa Moreira, G. Piluso, M. Vainzof, A. Belsito, L. Politano, A. A. Puca, M. R. Passos-Bueno and M. Zatz: Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nature Genet, 14(2), 195-8 (1996)

  • [15]C. Angelini, M. Fanin, M. P. Freda, D. J. Duggan, G. Siciliano and E. P. Hoffman: The clinical spectrum of sarcoglycanopathies. Neurology, 52(1), 176-179 (1999)

  • [16]J. M. Ervasti and K. P. Campbell: Membrane organization of the dystrophin-glycoprotein complex. Cell, 66(6), 1121-1131 (1991)

  • [17]J. Berger, S. Berger, T. E. Hall, G. J. Lieschke and P. D. Currie: Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology. Neuromuscular Disord, 20(12), 826-32 (2010)

  • [18]T. A. Rando: The dystrophin–glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve, 24(12), 1575-1594 (2001)

  • [19]L. Hemmings, P. A. Kuhlman and D. R. Critchley: Analysis of the actin-binding domain of alpha-actinin by mutagenesis and demonstration that dystrophin contains a functionally homologous domain. J Cell Biol, 116(6), 1369-80 (1992)

  • [20]M. Koenig, A. P. Monaco and L. M. Kunkel: The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell, 53(2), 219-228 (1988)

  • [21]D. Jung, B. Yang, J. Meyer, J. S. Chamberlain and K. P. Campbell: Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J Biol Chem, 270(45), 27305-10 (1995)

  • [22]M. D. Henry and K. P. Campbell: Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton. Curr Opin in Cell Biol, 8(5), 625-31 (1996)

  • [23]O. Ibraghimov-Beskrovnaya, J. M. Ervasti, C. J. Leveille, C. A. Slaughter, S. W. Sernett and K. P. Campbell: Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature, 355(6362), 696-702 (1992)

  • [24]N. R. Kramarcy, A. Vidal, S. C. Froehner and R. Sealock: Association of utrophin and multiple dystrophin short forms with the mammalian M(r) 58,000 dystrophin-associated protein (syntrophin). J Biol Chem, 269(4), 2870-6 (1994)

  • [25]S. H. Gee, R. Madhavan, S. R. Levinson, J. H. Caldwell, R. Sealock and S. C. Froehner: Interaction of Muscle and Brain Sodium Channels with Multiple Members of the Syntrophin Family of Dystrophin-Associated Proteins. J Neurosci, 18(1), 128-37 (1998)

  • [26]A. Hogan, L. Shepherd, J. Chabot, S. Quenneville, S. M. Prescott, M. K. Topham and S. H. Gee: Interaction of γ1-Syntrophin with Diacylglycerol Kinase-ζ. REGULATION OF NUCLEAR LOCALIZATION BY PDZ INTERACTIONS. J Biol Chem, 276(28), 26526-33 (2001)

  • [27]M. E. Adams, H. A. Mueller and S. C. Froehner: in vivo requirement of the alpha-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4. J Cell Biol, 155(1), 113-122 (2001)

  • [28]A. Abdelmoity, R. C. Padre, K. E. Burzynski, J. T. Stull and K. S. Lau: Neuronal nitric oxide synthase localizes through multiple structural motifs to the sarcolemma in mouse myotubes. FEBS Lett, 482(1-2), 65-70 (2000)

  • [29]L. Kobzik, M. B. Reid, D. S. Bredt and J. S. Stamler: Nitric oxide in skeletal muscle. Nature, 372(6506), 546-8 (1994)

  • [30]K. H. Holt, L. E. Lim, V. Straub, D. P. Venzke, F. Duclos, R. D. Anderson, B. L. Davidson and K. P. Campbell: Functional Rescue of the Sarcoglycan Complex in the BIO 14.6. Hamster Using δ-Sarcoglycan Gene Transfer. Mol Cell, 1(6), 841-848 (1998)

  • [31]H. M. Sadoulet-Puccio, M. Rajala and L. M. Kunkel: Dystrobrevin and dystrophin: An interaction through coiled-coil motifs. PNAS, 94(23), 12413-12418 (1997)

  • [32]R. H. Crosbie, J. Heighway, D. P. Venzke, J. C. Lee and K. P. Campbell: Sarcospan, the 25-kDa Transmembrane Component of the Dystrophin-Glycoprotein Complex. J Biol Chem, 272(50), 31221-4 (1997)

  • [33]R. H. Crosbie, C. S. Lebakken, K. H. Holt, D. P. Venzke, V. Straub, J. C. Lee, R. M. Grady, J. S. Chamberlain, J. R. Sanes and K. P. Campbell: Membrane Targeting and Stabilization of Sarcospan Is Mediated by the Sarcoglycan Subcomplex. J Cell Biol, 145(1), 153-165 (1999)

  • [34]D. Jung, F. Duclos, B. Apostol, V. Straub, J. C. Lee, V. Allamand, D. P. Venzke, Y. Sunada, C. R. Moomaw, C. J. Leveille, C. A. Slaughter, T. O. Crawford, J. D. McPherson and K. P. Campbell: Characterization of δ-Sarcoglycan, a Novel Component of the Oligomeric Sarcoglycan Complex Involved in Limb-Girdle Muscular Dystrophy. J Biol Chem, 271(50), 32321-32329 (1996)

  • [35]S. L. Roberds, R. D. Anderson, O. Ibraghimov-Beskrovnaya and K. P. Campbell: Primary Structure and Muscle-specfic Expression of the 50-kDa Dystrrophin-associated Glycoprotein (Adhalin). J Biol Chem, 268(32), 23739-23742 (1993)

  • [36]A. Carrié, F. Piccolo, F. Leturcq, C. de Toma, K. Azibi, C. Beldjord, J. M. Vallat, L. Merlini, T. Voit, C. Sewry, J. A. Urtizberea, N. Romero, F. M. Tomé, M. Fardeau, Y. Sunada, K. P. Campbell, J. C. Kaplan and M. Jeanpierre: Mutational diversity and hot spots in the α-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D). J Med Genet, 34(6), 470-475 (1997)

  • [37]D. J. Duggan, J. R. Gorospe, M. Fanin, E. P. Hoffman, C. Angelini, E. Pegoraro, S. Noguchi, E. Ozawa, W. Pendlebury, A. J. Waclawik, D. A. Duenas, I. Hausmanowa-Petrusewicz, A. Fidzianska, S. C. Bean, J. S. Haller, J. Bodensteiner, C. M. Greco, A. Pestronk, A. Berardinelli, D. F. Gelinas, H. Abram and R. W. Kuncl: Mutations in the Sarcoglycan Genes in Patients with Myopathy. N Engl J Med, 336(9), 618-625 (1997)

  • [38]D. Jung, F. Leturcq, Y. Sunada, F. Duclos, F. M. Tome, C. Moomaw, L. Merlini, K. Azibi, M. Chaouch, C. Slaughter, M. Fardeau, J. C. Kaplan and K. P. Campbell: Absence of γ-sarcoglycan (35 DAG) in autosomal recessive muscular dystrophy linked to chromosome 13q12. FEBS Lett, 381(1-2), 15-20 (1996)

  • [39]M. Yoshida, A. Suzuki, H. Yamamoto, S. Noguchi, Y. Mizuno and E. Ozawa: Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-D-glucoside. Eur J Biochem, 222(3), 1055-61 (1994)

  • [40]A. J. Ettinger, G. Feng and J. R. Sanes: ε-Sarcoglycan, a Broadly Expressed Homologue of the Gene Mutated in Limb-Girdle Muscular Dystrophy 2D. J Biol Chem, 272(51), 32534-8 (1997)

  • [41]M. T. Wheeler, S. Zarnegar and E. M. McNally: ζ-Sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy. Hum Mol Gen, 11(18), 2147-2154 (2002)

  • [42]R. Coral-Vazquez, R. D. Cohn, S. A. Moore, J. A. Hill, R. M. Weiss, R. L. Davisson, V. Straub, R. Barresi, D. Bansal, R. F. Hrstka, R. Williamson and K. P. Campbell: Disruption of the Sarcoglycan–Sarcospan Complex in Vascular Smooth Muscle. Cell, 98(4), 465-474(1999)

  • [43]F. Duclos, V. Straub, S. A. Moore, D. P. Venzke, R. F. Hrstka, R. H. Crosbie, M. Durbeej, C. S. Lebakken, A. J. Ettinger, J. van der Meulen, K. H. Holt, L. E. Lim, J. R. Sanes, B. L. Davidson, J. A. Faulkner, R. Williamson and K. P. Campbell: Progressive muscular dystrophy in α-sarcoglycan-deficient mice. J Cell Biol, 142(6), 1461-71 (1998)

  • [44]A. A. Hack, C. T. Ly, F. Jiang, C. J. Clendenin, K. S. Sigrist, R. L. Wollmann and E. M. McNally: γ-Sarcoglycan Deficiency Leads to Muscle Membrane Defects and Apoptosis Independent of Dystrophin. J Cell Biol, 142(5), 1279-1287 (1998)

  • [45]V. Straub, F. Duclos, D. P. Venzke, J. C. Lee, S. Cutshall, C. J. Leveille and K. P. Campbell: Molecular Pathogenesis of Muscle Degeneration in the δ-Sarcoglycan-Deficient Hamster. Am J Pathol, 153(5), 1623-1630 (1998)

  • [46]S. Noguchi, E. Wakabayashi, M. Imamura, M. Yoshida and E. Ozawa: Formation of sarcoglycan complex with differentiation in cultured myocytes. Eur J Biochem, 267(3), 640-8 (2000)

  • [47]W. Shi, Z. Chen, J. Schottenfeld, R. C. Stahl, L. M. Kunkel and Y. M. Chan: Specific assembly pathway of sarcoglycans is dependent on beta- and delta-sarcoglycan. Muscle Nerve, 29(3), 409-19 (2004)

  • [48]Y. M. Chan, C. G. Bonnemann, H. G. Lidov and L. M. Kunkel: Molecular Organization of Sarcoglycan Complex in Mouse Myotubes in Culture. J Cell Biol, 143(7), 2033-44 (1998)

  • [49]M. Vainzof, M. R. Passos-Bueno, M. Canovas, E. S. Moreira, R. C. Pavanello, S. K. Marie, L. V. Anderson, C. G. Bonnemann, E. M. McNally, V. Nigro, L. M. Kunkel and M. Zatz: The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Hum Mol Gen, 5(12), 1963-9 (1996)

  • [50]K. Matsumura, F. M. Tome, H. Collin, K. Azibi, M. Chaouch, J. C. Kaplan, M. Fardeau and K. P. Campbell: Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy. Nature, 359(6393), 320-2 (1992)

  • [51]R. Betto, L. Senter, S. Ceoldo, E. Tarricone, D. Biral and G. Salviati: Ecto-ATPase Activity of α-Sarcoglycan (Adhalin). J Biol Chem, 274(12), 7907-7912 (1999)

  • [52]D. Sandonà, S. Gastaldello, T. Martinello and R. Betto: Characterization of the ATP-hydrolysing activity of α-sarcoglycan. Biochemical J, 381(Pt 1), 105-112 (2004)

  • [53]M. Ryten, P. M. Dunn, J. T. Neary and G. Burnstock: ATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X5 receptor on satellite cells. J Cell Biol, 158(2), 345-355 (2002)

  • [54]E. M. McNally, D. Duggan, J. Rafael Gorospe, C. G. Bönnemann, M. Fanin, E. Pegoraro, H. G. W. Lidov, S. Noguchi, E. Ozawa, R. S. Finkel, R. P. Cruse, C. Angelini, L. M. Kunkel and E. P. Hoffman: Mutations That Disrupt the Carboxyl-Terminus of γ-Sarcoglycan Cause Muscular Dystrophy. Hum Mol Gen, 5(11), 1841-1847 (1996)

  • [55]N. J. Dickens, S. Beatson and C. P. Ponting: Cadherin-like domains in α-dystroglycan, α/ε-sarcoglycan and yeast and bacterial proteins. Curr Biol, 12(6), 197-199 (2002)

  • [56]B. Eymard, N. B. Romero, F. Leturcq, F. Piccolo, A. Carrie, M. Jeanpierre, H. Collin, N. Deburgrave, K. Azibi, M. Chaouch, L. Merlini, C. Themar-Noel, I. Penisson, M. Mayer, O. Tanguy, K. P. Campbell, J. C. Kaplan, F. M. Tome and M. Fardeau: Primary adhalinopathy (α-sarcoglycanopathy): Clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy. Neurology, 48(5), 1227-34 (1997)

  • [57]F. Piccolo, S. L. Roberds, M. Jeanpierre, F. Leturcq, K. Azibi, C. Beldjord, A. Carrie, D. Recan, M. Chaouch, A. Reghis and et al.: Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity. Nature Genet, 10(2), 243-245 (1995)

  • [58]M. Imamura, Y. Mochizuki, E. Engvall and S. Takeda: ε-sarcoglycan compensates for lack of α-sarcoglycan in a mouse model of limb-girdle muscular dystrophy. Hum Mol Gen, 14(6), 775-83 (2005)

  • [59]R. Barresi, S. A. Moore, C. A. Stolle, J. R. Mendell and K. P. Campbell: Expression of γ-Sarcoglycan in Smooth Muscle and Its Interaction with the Smooth Muscle Sarcoglycan-Sarcospan Complex. J Biol Chem, 275(49), 38554-38560 (2000)

  • [60]L. A. Liu and E. Engvall: Sarcoglycan Isoforms in Skeletal Muscle. J Biol Chem, 274(53), 38171-38176 (1999)

  • [61]M. Bartoli, E. Gicquel, L. Barrault, T. Soheili, M. Malissen, B. Malissen, N. Vincent-Lacaze, N. Perez, B. Udd, O. Danos and I. Richard: Mannosidase I inhibition rescues the human α-sarcoglycan R77C recurrent mutation. Hum Mol Gen, 17(9), 1214-21 (2008)

  • [62]K. Kobuke, F. Piccolo, K. W. Garringer, S. A. Moore, E. Sweezer, B. Yang and K. P. Campbell: A common disease-associated missense mutation in alpha-sarcoglycan fails to cause muscular dystrophy in mice. Hum Mol Gen, 17(9), 1201-13 (2008)

  • [63]F. Fougerousse, M. Durand, L. Suel, O. Pourquie, A. L. Delezoide, N. B. Romero, M. Abitbol and J. S. Beckmann: Expression of genes (CAPN3, SGCA, SGCB, and TTN) involved in progressive muscular dystrophies during early human development. Genomics, 48(2), 145-56 (1998)

  • [64]J. Chen, W. Shi, Y. Zhang, R. Sokol, H. Cai, M. Lun, B. F. Moore, M. J. Farber, J. S. Stepanchick, C. G. Bonnemann and Y. M. Chan: Identification of functional domains in sarcoglycans essential for their interaction and plasma membrane targeting. Exp Cell Res, 312(9), 1610-25 (2006)

  • [65]C. G. Bönnemann, J. Wong, C. B. Hamida, M. B. Hamida, F. Hentati and L. M. Kunkel: LGMD 2E in Tunisia is caused by a homozygous missense mutation in β-sarcoglycan exon 3. Neuromuscular Disord, 8(3–4), 193-197 (1998)

  • [66]K. Araishi, T. Sasaoka, M. Imamura, S. Noguchi, H. Hama, E. Wakabayashi, M. Yoshida, T. Hori and E. Ozawa: Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in β-sarcoglycan-deficient mice. Hum Mol Gen, 8(9), 1589-98 (1999)

  • [67]C. Semplicini, J. Vissing, J. R. Dahlqvist, T. Stojkovic, L. Bello, N. Witting, M. Duno, F. Leturcq, C. Bertolin, P. D’Ambrosio, B. Eymard, C. Angelini, L. Politano, P. Laforet and E. Pegoraro: Clinical and genetic spectrum in limb-girdle muscular dystrophy type 2E. Neurology, 84(17), 1772-1781 (2015)

  • [68]M. Durbeej, R. D. Cohn, R. F. Hrstka, S. A. Moore, V. Allamand, B. L. Davidson, R. A. Williamson and K. P. Campbell: Disruption of the β-Sarcoglycan Gene Reveals Pathogenetic Complexity of Limb-Girdle Muscular Dystrophy Type 2E. Mol Cell, 5(1), 141-151 (2000)

  • [69]C. G. Bönnemann, M. R. Passos-Bueno, E. M. McNally, M. Vainzof, E. d. S. Moreira, S. K. Marie, R. C. M. Pavanello, S. Noguchi, E. Ozawa, M. Zatz and L. M. Kunkel: Genomic Screening for β-Sarcoglycan Gene Mutations: Missense Mutations May Cause Severe Limb-girdle Muscular Dystrophy Type 2E (LGMD 2E). Hum Mol Gen, 5(12), 1953-1961 (1996)

  • [70]R. D. Cohn, M. Durbeej, S. A. Moore, R. Coral-Vazquez, xF, S. Prouty and K. P. Campbell: Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex. J Clin Invest, 107(2), R1-R7 (2001)

  • [71]M. J. Allikian, A. A. Hack, S. Mewborn, U. Mayer and E. M. McNally: Genetic compensation for sarcoglycan loss by integrin α7β1 in muscle. J Cell Sci, 117(17), 3821-3830 (2004)

  • [72]F. Piccolo, M. Jeanpierre, F. Leturcq, C. Dodé, K. Azibi, A. Toutain, L. Merlini, L. Jarre, C. Navarro, R. Krishnamoorthy, F. M. S. Tomé, J. A. Urtizberea, J. S. Beckmann, K. P. Campbell and J.-C. Kaplan: A founder mutation in the γ-Sarcoglycan gene of Gypsies possibly predating their migration out of India. Hum Mol Gen, 5(12), 2019-2022 (1996)

  • [73]R. H. Crosbie, L. E. Lim, S. A. Moore, M. Hirano, A. P. Hays, S. W. Maybaum, H. Collin, S. A. Dovico, C. A. Stolle, M. Fardeau, F. M. S. Tomé and K. P. Campbell: Molecular and genetic characterization of sarcospan: insights into sarcoglycan–sarcospan interactions. Hum Mol Gen, 9(13), 2019-2027 (2000)

  • [74]X. Zhu, M. Hadhazy, M. E. Groh, M. T. Wheeler, R. Wollmann and E. M. McNally: Overexpression of gamma-sarcoglycan induces severe muscular dystrophy. Implications for the regulation of Sarcoglycan assembly. J Biol Chem, 276(24), 21785-90 (2001)

  • [75]A. Sakamoto, K. Ono, M. Abe, G. Jasmin, T. Eki, Y. Murakami, T. Masaki, T. Toyo-oka and F. Hanaoka: Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, δ-sarcoglycan, in hamster: An animal model of disrupted dystrophin-associate dglycoprotein complex. PNAS, 94(25), 13873-13878 (1997)

  • [76]T. G. Thompson, Y.-M. Chan, A. A. Hack, M. Brosius, M. Rajala, H. G. W. Lidov, E. M. McNally, S. Watkins and L. M. Kunkel: Filamin 2 (FLN2): A Muscle-specific Sarcoglycan Interacting Protein. J Cell Biol, 148(1), 115-126 (2000)

  • [77]T. P. Stossel, J. Condeelis, L. Cooley, J. H. Hartwig, A. Noegel, M. Schleicher and S. S. Shapiro: Filamins as integrators of cell mechanics and signalling. Nature Rev Mol Cell Biol, 2(2), 138-145 (2001)

  • [78]D. T. Loo, S. B. Kanner and A. Aruffo: Filamin binds to the cytoplasmic domain of the β1-integrin. Identification of amino acids responsible for this interaction. J Biol Chem, 273(36), 23304-12 (1998)

  • [79]M. Stahlhut and B. van Deurs: Identification of Filamin as a Novel Ligand for Caveolin-1: Evidence for the Organization of Caveolin-1–associated Membrane Domains by the Actin Cytoskeleton. Mol Biol Cell, 11(1), 325-337 (2000)

  • [80]F. Homburger, J. R. Baker, C. W. Nixon and R. Whitney: Primary, Generalized Polymyopathy and Cardiac Necrosis in an Inbred Line of Syrian Hamsters. Pharmacology, 6(5), 339-345 (1962)

  • [81]V. Nigro, Y. Okazaki, A. Belsito, G. Piluso, Y. Matsuda, L. Politano, G. Nigro, C. Ventura, C. Abbondanza, A. M. Molinari, D. Acampora, M. Nishimura, Y. Hayashizaki and G. A. Puca: Identification of the Syrian Hamster Cardiomyopathy Gene. Hum Mol Gen, 6(4), 601-607 (1997)

  • [82]S. P. Chambers, L. V. B. Anderson, G. M. Maguire, A. Dodd and D. R. Love: Sarcoglycans of the zebrafish: orthology and localization to the sarcolemma and myosepta of muscle. Biochem Biophys Res Commun, 303(2), 488-495 (2003)

  • [83]J. Berger and P. D. Currie: Zebrafish models flex their muscles to shed light on muscular dystrophies. Dis Model Mech, 5(6), 726-732 (2012)

  • [84]L. Cheng, X. F. Guo, X. Y. Yang, M. Chong, J. Cheng, G. Li, Y. H. Gui and D. R. Lu: δ-sarcoglycan is necessary for early heart and muscle development in zebrafish. Biochem Biophys Res Commun, 344(4), 1290-9 (2006)

  • [85]J. R. Guyon, A. N. Mosley, S. J. Jun, F. Montanaro, L. S. Steffen, Y. Zhou, V. Nigro, L. I. Zon and L. M. Kunkel: δ-Sarcoglycan is required for early zebrafish muscle organization. Exp Cell Res, 304(1), 105-115 (2005)

  • [86]V. Nigro, G. Piluso, A. Belsito, L. Politano, A. A. Puca, S. Papparella, E. Rossi, G. Viglietto, M. G. Esposito, C. Abbondanza, N. Medici, A. M. Molinari, G. Nigro and G. A. Puca: Identification of a Novel Sarcoglycan Gene at 5q33 Encoding a Sarcolemmal 35 kDa Glycoprotein. Hum Mol Gen, 5(8), 1179-1186 (1996)

  • [87]E. M. McNally, C. T. Ly and L. M. Kunkel: Human epsilon-sarcoglycan is highly related to alpha-sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene. FEBS Lett, 422(1), 27-32 (1998)

  • [88]A. Zimprich, M. Grabowski, F. Asmus, M. Naumann, D. Berg, M. Bertram, K. Scheidtmann, P. Kern, J. Winkelmann, B. Muller-Myhsok, L. Riedel, M. Bauer, T. Muller, M. Castro, T. Meitinger, T. M. Strom and T. Gasser: Mutations in the gene encoding ε-sarcoglycan cause myoclonus-dystonia syndrome. Nature Genet, 29(1), 66-9 (2001)

  • [89]K. Shiga, H. Yoshioka, T. Matsumiya, I. Kimura, S. Takeda and M. Imamura: ζ-sarcoglycan is a functional homologue of γ-sarcoglycan in the formation of the sarcoglycan complex. Exp Cell Res, 312(11), 2083-92 (2006)

Article Metrics

  • Information

  • Download

  • Contents

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Abstract

In skeletal muscle, the dystrophin-associated glycoprotein complex forms a link between the actin cytoskeleton and the extracellular matrix that is critical for muscle integrity. Within this complex resides the sarcoglycan subcomplex, which consists of four transmembrane glycoproteins (alpha-, beta-, gamma-, and delta-sarcoglycan). During assembly, beta-sarcoglycan tightly associates with delta-sarcoglycan to form a functional core that then recruits gamma- and alpha-sarcoglycan to form the sarcoglycan complex. Together with sarcospan, the sarcoglycan complex binds other components of the dystrophin-associated glycoprotein complex and integrates into the myofibre’s membrane. Once integrated, the sarcoglycan complex plays a pivotal role in mechanically stabilising the sarcolemma as well as the dystrophin-associated glycoprotein complex. Additionally, the sarcoglycan complex undergoes chemical modifications in response to muscle contractions, thereby transducing mechanical information into a cellular signal. Mutations in the sarcoglycans induce limb girdle muscular dystrophy, and several animal models have been established to study the molecular biology and function of the sarcoglycan complex. This review discusses the role of the sarcoglycan complex in skeletal muscle and describes the functional deficiencies that lead to muscular dystrophies.

Keywords

  • Skeletal muscle
  • Dystrophin-associated glycoprotein complex
  • Sarcoglycan
  • Limb girdle muscular dystrophy
  • Review

References